Woman 40 plus

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.004126.09.16
Date of registration and renewal:19.09.2016
Dosage form: & nbspTablets weighing 900 mg - in consumer packaging - for sale to the population, in the "in bulk" package of 20 kg - for subsequent packaging
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes Raw materials for dietary supplements
Classification "Clinical" & nbsp Supplements containing selenium
Composition: & nbspVitamin C, A, E, boron, sodium selenite, citrus bioflavonoids, root cane extract, paraaminobenzoic acid, inositol, glutamic acid, bromelain, papain, broccoli extract, green tea leaf extract, grape seed extract, silicon dioxide, croscarmellose sodium, magnesium stearate.
Scope: & nbspTo provide the population with a supplementary source of vitamins C, A, E, boron, selenium, a source of para-amino-benzoic acid, catechins, and also for subsequent packaging (in the "in bulk" package) as a biologically active food additive for women (APPENDIX).
Suggested Usage: & nbspAdults take 1 tablet a day with meals. Duration of admission is 1 month. If necessary, the reception can be repeated.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding. Before use, it is recommended to consult a doctor.
Special instructions:The product in the "in bulk" package is intended for subsequent packaging, not subject to retail sale to the public.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children at room temperature.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.002126.05.16 of 05/17/2016, expert opinions of the Research Institute for Nutrition of the Russian Academy of Medical Sciences No. 72 / E-1064 / b-10 of 25.11.2010, FGBU NII RAMS №72 / Э-614 / б-14 of 19.06.2014, FGBUN "FIC of nutrition and biotechnology" №529 / Э-689 / б-16 of 01/09/2016.
Recipient:Pharmamed, AOPharmamed, AO Russian Federation
Information update date: & nbsp09.10.2016
Instructions
Up